Results 271 to 280 of about 175,779 (327)

Clinical management of CMML—State of the art

British Journal of Haematology, EarlyView.
Patients with chronic myelomonocytic leukaemia (CMML) typically present with clinical feature including splenomegaly, constitutional symptoms and autoimmune phenomena, as well as with pathological blood counts and biological features in the marrow. These characteristics may influence the assignment to prognostic categories such as the CPSSmol and also ...
K. Nachtkamp, F. Schulz, N. Gattermann, U. Germing   +3 more
wiley   +1 more source

Incidence and Outcomes of Neutropenic Enterocolitis Post-stem Cell Transplant for Hematological Malignancies: A Retrospective Study in Australia. [PDF]

Cureus
Francis S.
europepmc   +1 more source

Prevalence of myeloid gene alterations in paediatric cutaneous and systemic mastocytosis

British Journal of Haematology, EarlyView.
A total of 69 children with paediatric mastocytosis, including cutaneous and systemic subtypes, were enrolled in a prospective natural history study (NCT00044122). They underwent next‐generation sequencing of peripheral blood to assess myeloid gene alterations.
Xiaoping Sun, Chen Wang, Dean D. Metcalfe, Melody C. Carter, Irina Maric   +4 more
wiley   +1 more source

Sequencing of chemotherapy in total neoadjuvant treatment for rectal cancer does not predict radiation-induced lymphopenia. [PDF]

Radiol Oncol
Orazem M, Velenik V, Ihan A.
europepmc   +1 more source

Efficacy and safety of HRS‐5965 monotherapy in complement inhibitor–naïve patients with paroxysmal nocturnal haemoglobinuria

British Journal of Haematology, EarlyView.
Summary Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, life‐threatening disorder characterized by complement‐mediated haemolysis, leading to anaemia and thrombosis. HRS‐5965 is a novel, oral, selective complement factor B inhibitor targeting the alternative pathway, potentially reducing both intra‐ and extravascular haemolysis.
Li Zhang, Ziwei Liu, Xin Zhao, Bin Hu, Rong Huang, Chang Shu, Fengkui Zhang, Bing Han   +7 more
wiley   +1 more source

Management of Graves Disease With Co-Existing Duffy-Null Phenotype. [PDF]

JCEM Case Rep
Ferri GM, Chua C, Trovato AR, Campos A, Sloan M, Haddady S.   +5 more
europepmc   +1 more source

Allogeneic transplantation after failure of chimeric antigen receptor‐T cells and exposure to bispecific antibodies: Feasibility, safety and survival outcomes

British Journal of Haematology, EarlyView.
Summary Clinical outcome after chimeric antigen receptor (CAR)‐T‐cell failure in large B‐cell lymphoma (LBCL) is dismal. Allogeneic stem cell transplantation (alloSCT) represents a potentially curative salvage for relapsed/refractory LBCL, although concerns remain regarding its feasibility and safety in patients exposed to CAR‐T and bispecific ...
Angelica Barone, Chiara De Philippis, Federico Stella, Anna Dodero, Barbara Sarina, Martina Pennisi, Armando Santoro, Carmelo Carlo‐Stella, Anna Guidetti, Stefania Bramanti, Paolo Corradini   +10 more
wiley   +1 more source

Comorbidity patterns and immune-metabolic differences in patients with acute-episode of schizophrenia spectrum disorders. [PDF]

Schizophrenia (Heidelb)
Wu G, Dong Z, Li Z, Zhao Q, Chen S, Dong Q, Huang L, Zhang Y, Wang X, Chen S, Liu H, Sun Z, Ban S, Tian B, Tan Y.   +14 more
europepmc   +1 more source

Variations in haematological and inflammatory biomarkers and their association with Plasmodium falciparum malaria: a cross-sectional comparative study at a clinic in Ghana. [PDF]

Malar J
Bohli JK, Ansah PB, Kwamena TE, Allotey E, Duneeh RV, Yeboah EB, Addo L, Kyeremeh R, Kwadzokpui PK, Ablordey K.   +9 more
europepmc   +1 more source

Multi‐pronged analysis of pediatric low‐grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations

Brain Pathology, EarlyView.
A multi pronged analysis approach revealed distinct neoplastic populations in PA and GG. Non‐neoplastic populations in PA showed higher levels of immune mobilizing chemokines in PA compared to GG. Abstract Pediatric low‐grade gliomas (pLGG) comprise 35% of all brain tumors.
Shadi Zahedi, Kent Riemondy, Tian Liu, Andrea M. Griesinger, Andrew M. Donson, April A. Apfelbaum, Rui Fu, Julian Grandvallet Contreras, Michele Crespo, John DeSisto, Madeline M. Groat, Emil Bratbak, Adam Green, Todd C. Hankinson, Michael Handler, Rajeev Vibhakar, Nicholas Willard, Nicholas K. Foreman, Tzu Phang, Jean Mulcahy Levy   +19 more
wiley   +1 more source